Matteo Dugo

13PUBLICATIONS
99CO-AUTHORS
Molecular targetsPredictive and prognostic markersInfant and child healthVirology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 04, 2025
Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies.

Maurizio Callari, Matteo Dugo, Marco Barreca

|Sep 23, 2024
The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer.

Matteo Dugo, Chiun-Sheng Huang, Daniel Egle

|Jan 04, 2024
Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single case.

Viviana Vallacchi, Elisabetta Vergani, Mara Cossa

|Feb 08, 2023
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer.

Lorenzo Castagnoli, Simona Corso, Alma Franceschini

|Jul 02, 2021
Integrative Transcriptomic Analysis Reveals Distinctive Molecular Traits and Novel Subtypes of Collecting Duct Carcinoma.

Chiara Gargiuli, Pierangela Sepe, Anna Tessari

|Jun 29, 2021
Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients.

Darawan Rinchai, Elena Verzoni, Veronica Huber

Pageof 3

Frequent Collaborators

4 joint publications

Loris De Cecco

3 joint publications

Chiara Gargiuli

2 joint publications

Lajos Pusztai

2 joint publications

Lucia Del Mastro